#ASCOGU25 hashtag - Bluesky

@drtimos.bsky.social

2 days ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TRnBZB !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

1 week ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TRcw4G !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

3 weeks ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TRRj7w !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

4 weeks ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TRGBBY !

#Oncology #SocialListening #LucidQuest

1 0 0 0

@drtimos.bsky.social

1 month ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TR5FBn !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

1 month ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TQwYdy !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

1 month ago

ASCO_GU_ 2025_Social_Media_Report.pdf 2025 Genitourinary Cancers Symposium Accelerate your success ASCO GU 2025 • Social Media Insights at Medical / Scientific Congresses 3 • Our methodology 4 • Key takeaways 5 • Conference-related SM activity over time 6 • Top hashtags used 7 • Top discussion themes 8 • Top Leading Voices 9 • Sentiment Analysis 10 • Most frequently used words and phrases 11 • LucidQuest’s SM Insights’ capabilities 12 • Get in touch 13 1. Insights on which and which to avoid hashtags that can to your preferred resonates with with existing or The LucidQuest Social Media Insights team monitored approximately 16.1K posts before, during, and after ASCO GU 2025 to identify key hashtags, top discussion themes, top Our team analyzed the absolute frequency of relevant hashtags found in 2.5K posts, and compiled a list of the top most frequent ones. The text of top 500 posts was analyzed to identify the top discussion themes and most frequent phrases and words used. We leveraged our LQ algorithm, which takes into account both user activity and popularity, to identify the top Leading Voices at the event. Finally, we analyzed the text of top 500 posts to assess overall sentiment and audience perceptions of the conference We filtered posts in the top 25% of views to identify the top 500 ones.

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TQlR2m !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

2 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TQZ1zb !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

2 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TQQByH !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

2 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TQGMGG !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

2 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TQ7Nkk !

#Oncology #SocialListening #LucidQuest

1 0 0 0

@drtimos.bsky.social

3 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf 2025 Genitourinary Cancers Symposium Accelerate your success ASCO GU 2025 • Social Media Insights at Medical / Scientific Congresses 3 • Our methodology 4 • Key takeaways 5 • Conference-related SM activity over time 6 • Top hashtags used 7 • Top discussion themes 8 • Top Leading Voices 9 • Sentiment Analysis 10 • Most frequently used words and phrases 11 • LucidQuest’s SM Insights’ capabilities 12 • Get in touch 13 1. Insights on which and which to avoid hashtags that can to your preferred resonates with with existing or The LucidQuest Social Media Insights team monitored approximately 16.1K posts before, during, and after ASCO GU 2025 to identify key hashtags, top discussion themes, top Our team analyzed the absolute frequency of relevant hashtags found in 2.5K posts, and compiled a list of the top most frequent ones. The text of top 500 posts was analyzed to identify the top discussion themes and most frequent phrases and words used. We leveraged our LQ algorithm, which takes into account both user activity and popularity, to identify the top Leading Voices at the event. Finally, we analyzed the text of top 500 posts to assess overall sentiment and audience perceptions of the conference We filtered posts in the top 25% of views to identify the top 500 ones.

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TQ1gfb !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

3 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TPvzdc !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

3 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TPn1HZ !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

3 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TPf5Mb !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

4 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TPVhgS !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

4 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TPMkjp !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

4 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TPF32b !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

4 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TP5Wsb !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

5 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TNyGFw !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

5 months ago

Here's a preview of your destination drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TNqWgG !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

5 months ago

Here's a preview of your destination drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TNhXS7 !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

5 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf 403. That’s an error. We're sorry, but you do not have access to this page. That’s all we know.

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TNY1gJ !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

6 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TNP7zz !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

6 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TNDvdQ !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

6 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TN5HmY !

#Oncology #SocialListening #LucidQuest

1 0 0 0

@drtimos.bsky.social

6 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TMxy2Q !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

7 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TMp4gC !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

7 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf 2025 Genitourinary Cancers Symposium • Our methodology 4 • Key takeaways 5 • Conference-related SM activity over time 6 • Top hashtags used 7 • Top discussion themes 8 • Top Leading Voices 9 • Most frequently used words and phrases 11 • LucidQuest’s SM Insights’ capabilities 12 The LucidQuest Social Media Insights team monitored approximately 16.1K posts before, during, and after ASCO GU 2025 to identify key hashtags, top discussion themes, top We leveraged our LQ algorithm, which takes into account both user

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TMg3w9 !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

7 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TMXWWG !

#Oncology #SocialListening #LucidQuest

0 0 0 0